Literature DB >> 11148134

Secretory granules of mast cells accumulate mature and immature MHC class II molecules.

H Vincent-Schneider1, C Théry, D Mazzeo, D Tenza, G Raposo, C Bonnerot.   

Abstract

Bone marrow-derived mast cells as well as dendritic cells, macrophages and B lymphocytes express major histocompatibility complex (MHC) class II molecules. In mast cells, the majority of MHC class II molecules reside in intracellular cell type-specific compartments, secretory granules. To understand the molecular basis for the localisation of MHC class II molecules in secretory granules, MHC class II molecules were expressed, together with the invariant chain, in the mast cell line, RBL-2H3. Using electron and confocal microscopy, we observed that in RBL-2H3 cells, mature and immature class II molecules accumulate in secretory granules. Two particular features of class II transport accounted for this intracellular localization: first, a large fraction of newly synthesized MHC class II molecules remained associated with invariant chain fragments. This defect, resulting in a slower rate of MHC class II maturation, was ascribed to a low cathepsin S activity. Second, although a small fraction of class II dimers matured (i.e. became free of invariant chain), allowing their association with antigenic peptides, they were retained in secretory granules. As a consequence of this intracellular localization, cell surface expression of class II molecules was strongly increased by cell activation stimuli which induced the release of the contents of secretory granules. Our results suggest that antigen presentation, and thereby antigen specific T cell stimulation, are regulated in mast cells by stimuli which induce mast cell activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11148134     DOI: 10.1242/jcs.114.2.323

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  16 in total

1.  Stimuli from conspecifics influence brain mast cell population in male rats.

Authors:  Lori Asarian; Eleazer Yousefzadeh; Ann-Judith Silverman; Rae Silver
Journal:  Horm Behav       Date:  2002-08       Impact factor: 3.587

2.  Functional analysis of monocyte MHC class II compartments.

Authors:  Allyson Bunbury; Ilaria Potolicchio; Radhashree Maitra; Laura Santambrogio
Journal:  FASEB J       Date:  2008-09-24       Impact factor: 5.191

3.  Cognate interactions between mast cells and helper T lymphocytes.

Authors:  Salvatore Valitutti; Eric Espinosa
Journal:  Self Nonself       Date:  2010-03-17

Review 4.  The impact of bacterial infection on mast cell degranulation.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

Review 5.  Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation.

Authors:  Steven Maltby; Khashayarsha Khazaie; Kelly M McNagny
Journal:  Biochim Biophys Acta       Date:  2009-02-21

6.  T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis.

Authors:  Elias Gounaris; Nichole R Blatner; Kristen Dennis; Fay Magnusson; Michael F Gurish; Terry B Strom; Philipp Beckhove; Fotini Gounari; Khashayarsha Khazaie
Journal:  Cancer Res       Date:  2009-07-01       Impact factor: 12.701

7.  Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin.

Authors:  James B McLachlan; Drew M Catron; James J Moon; Marc K Jenkins
Journal:  Immunity       Date:  2009-02-05       Impact factor: 31.745

8.  The tetraspanin CD63 is required for efficient IgE-mediated mast cell degranulation and anaphylaxis.

Authors:  Stefan Kraft; Marie-Hélène Jouvin; Nitin Kulkarni; Sandra Kissing; Ellen S Morgan; Ann M Dvorak; Bernd Schröder; Paul Saftig; Jean-Pierre Kinet
Journal:  J Immunol       Date:  2013-08-14       Impact factor: 5.422

9.  Mast cell synapses and exosomes: membrane contacts for information exchange.

Authors:  Amanda Carroll-Portillo; Zurab Surviladze; Alessandra Cambi; Diane S Lidke; Bridget S Wilson
Journal:  Front Immunol       Date:  2012-03-15       Impact factor: 7.561

10.  The severity of experimental autoimmune cystitis can be ameliorated by anti-CXCL10 Ab treatment.

Authors:  Udai P Singh; Narendra P Singh; Honbing Guan; Venkatesh L Hegde; Robert L Price; Dennis D Taub; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.